dda355b-4b33-5bda-9ee8-118da648d975

Property	Value
?:citation	<https://twitter.com/BestForBritain/status/1391017293749043208?> <https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2021/tagrisso-adjuvant-receives-positive-chmp-opinion.html?> <https://www.ema.europa.eu/en/documents/product-information/tagrisso-epar-product-information_en.pdf?> <https://www.ema.europa.eu/en/medicines/human/EPAR/tagrisso?> <https://www.ema.europa.eu/en/medicines/human/summaries-opinion/tagrisso?> <https://www.england.nhs.uk/2021/05/nhs-to-offer-new-drug-that-halves-the-risk-of-cancer-returning/?> <https://www.express.co.uk/life-style/health/1432904/UK-new-lung-cancer-drug-brexit-deal?> <https://www.facebook.com/BestForBritain/photos/a.1881791845393544/2941722796067105/?type%3D3%26__xts__[0]%3D68.ARCjUQfZwJHJzuz11OwkwIZrmiVmbPldIaOpmz4JLvNJbkX1ddBIkMc5trBuuZAEmzdjIEDvtwchcSf2I95SDpZtRydjju0EraDZOnp7L_xgA9RUYVRG9Xi04REpOd0i25pdCdd7VmT7WcZgD-4xru5zxH4yeQgtx97thyueao7nQ3-eGBeXqfhYHO9GgtGEhbkmY3LfKEVx8H12jUHrPeNuY5UgUAb65BjiowxLjRbht1FIG_ufNtjjWYE1--USB2kW_4k6EYxOA94O6mTrr4f7bjU0dKkOrzY> <https://www.facebook.com/NHSNewsday/photos/a.685742444964996/1598867226985842/?type%3D3%26__xts__[0]%3D68.ARDAvUbW9euEQaM7_5Vr-RqQPl_Vivo1paDTKOodolHtwZmP1lybNr9w1FGtX_m5ThU4VJw8AP8vFp9aCdDcNrhghvZmp6wfaSleXXXhromBE-jmGsyDs1gogzicE1mBpc2zGECUGSF3h0eEtw3pZuv160MgCsd4XFPQb5nZR_WMtWwoEw6KIiQhsUgii_tgwFZmIrRmIzzBoEkUz8dRHzAmL7UVT4YxLb4F4-Kr8rXDQimcbxSQv5Z7TjybLU2W-kFN1nosbAVtjeKnxjk9DK2D0P9Gz6PSnA> <https://www.facebook.com/help/publisher/182222309230722?> <https://www.fullfact.org/blog/2019/jan/full-fact-start-checking-facebook-content-third-party-factchecking-initiative-reaches-uk/?> <https://www.fullfact.org/health/Rishi-Sunak-patient-flow-discharge-rates/?utm_source%3Dcontent_page%26utm_medium%3Drelated_content> <https://www.fullfact.org/health/cancer-cannabis/?utm_source%3Dcontent_page%26utm_medium%3Drelated_content> <https://www.fullfact.org/health/claire-bridges-legs-amputated/?utm_source%3Dcontent_page%26utm_medium%3Drelated_content> <https://www.fullfact.org/health/vaping-harms/?utm_source%3Dcontent_page%26utm_medium%3Drelated_content> <https://www.fullfact.org/online/defibrillators-schools-covid-vaccine-deaths/?utm_source%3Dcontent_page%26utm_medium%3Drelated_content> <https://www.gov.uk/government/news/uk-medicines-regulator-issues-its-first-authorisation-under-project-orbis?> <https://www.gov.uk/guidance/guidance-on-project-orbis?> <https://www.nhs.uk/conditions/lung-cancer/diagnosis?>
is ?:itemReviewed of	claimskg:claim_review/ddfe9f2d-a317-59cb-b4ea-2e9be1b2ce58
?:keywords	claimskg:keyword/8620acfe-2344-5432-9bfc-bf6fed6a6c88 claimskg:keyword/ec8846d2-717f-54c8-8617-e8b0df46ba31
?:mentions	claimskg:mention/15eaf0e8-b5c6-5161-b2d5-0f7dd01b4c42 claimskg:mention/87d62b21-d2c8-58c5-98ce-0ce3be0e52b0 claimskg:mention/f7a276d6-eab9-542a-a9fe-21f23dce1b3a
?:text	Osimertinib (the lung cancer medication) has been licensed in the EU for use since 2016. (en)
rdf:type	<http://schema.org/CreativeWork>